How do immune cells overcome the blood-brain barrier in multiple sclerosis?

Cited by (404)

Items 301–400 of 404

  1. Effectiveness of Anti-Cluster of Differentiation 20 as a Disease-Modifying Therapy in Multiple Sclerosis Across Its Different Phenotypes at the University Hospital of Caen
    Moayyad S Bauthman · 2022 · Cureus
  2. EGFL7 – a potential therapeutic target for multiple sclerosis?
    Timo Uphaus, Frauke Zipp, Catherine Larochelle · 2018 · Expert Opinion on Therapeutic Targets
  3. Brain-infiltrating CD8 T cells retain functional activity to protect against acute Zika virus infection
    Jaehui Kim, W M Lee, Do Yeon Kim, Keun Bon Ku, Young-Chan Kwon, Kyun‐Do Kim, Chonsaeng Kim, Dae‐Gyun Ahn, Seong Jun Kim, Sungjun Park · 2026 · Scientific Reports
  4. Matrix Metalloproteinase-9 Gene Polymorphisms in South-West Iranian Multiple Sclerosis (MS) Patients
    Narjes Khatoun Shabani Sadr, Hamid Galehdari, Tahere Seifi, Nooshin Delfan, S.R. Khatami, Atousa Hafizi · 2019 · Russian Journal of Genetics
  5. The use of gold nanoparticles in the treatment of neurodegenerative diseases
    Gustavo de Bem Silveira, Laura de Roch Casagrande, Ligia Milanez Venturini, Jade de Oliveira, Paulo César Lock Silveira · 2024 · Elsevier eBooks
  6. The Utility of Miniaturized Adsorbers in Exploring the Cellular and Molecular Effects of Blood Purification: A Pilot Study with a Focus on Immunoadsorption in Multiple Sclerosis
    Andreas Körtge, Anne Breitrück, Sandra Doß, Jacqueline Hofrichter, Sophie-Charlotte Nelz, Horst Krüsemann, Reinhold Wasserkort, Brit Fitzner, Michael Hecker, Steffen R Mitzner et al. · 2024 · International Journal of Molecular Sciences
  7. Astrocytic stress response is induced by exposure to astrocyte-binding antibodies expressed by plasmablasts from pediatric patients with acute transverse myelitis
    Chad Smith, Kiel M. Telesford, Sara G. M. Piccirillo, Yamhilette Licón-Muñoz, Wei Zhang, Key M. Tse, Jacqueline R. Rivas, Chaitanya Joshi, Dilan S. Shah, Angela X. Wu et al. · 2024 · Journal of Neuroinflammation
  8. A ceramide theory of multiple sclerosis
    Ari Rappoport · 2025 · Elsevier eBooks
  9. Lymphocytes Protect Cortical Neurons Against Excitotoxicity Mediated by Kainic Acid, an in vitro Model for Neurodegeneration
    Rajeev Shrestha, Owain R. Millington, James M. Brewer, Trevor John Bushell · 2015 · Kathmandu University Medical Journal
  10. Macrophage migration inhibitory factor modulates formalin induced behaviors in rats
    Alexandru‐Florian Deftu, Paolo Fiorenzani, Ilaria Ceccarelli, Jessica Pinassi, Martina Gambaretto, Violeta Ristoiu, Luana Ricci Paulesu, A. M. Aloisi · 2016 · Animal Biology
  11. Effect of six weeks forced and voluntary training before EAE induction on the expression of some adhesive molecules affecting the blood-brain barrier permeability
    Mohammad Reza Rahmati, Mohammad Reza Kordi, A A Ravasi · 2022 · Journal of Sport and Exercise Physiology
  12. Attenuation of Immune Suppression to Complement Glioma Immunotherapy
    Cameron S. Field · 2016
  13. Progenitor Cells Play a Role in Reinstatement of Ethanol Seeking in Adult Male and Female Ethanol Dependent Rats
    Hannah A. Nonoguchi, Michael Jin, Rajitha Narreddy, Timothy Wee Shang Kouo, Mahasweta Nayak, Wulfran Trenet, Chitra D. Mandyam · 2023 · International Journal of Molecular Sciences
  14. Prednisolone Targets Claudins in Mouse Brain Blood Vessels
    Alexander Georgievich Markov, Anastasia E. Bikmurzina, Arina Alexandrovna Fedorova, Екатерина Павловна Виноградова, Natalia M. Kruglova, Igor I. Krivoi, Salah Amasheh · 2023 · International Journal of Molecular Sciences
  15. Efficiency of Nanoparticles (Micromage-B) in the Complex Treatment of Multiple Sclerosis
    Andrey Belousov · 2023 · Clinical Research and Clinical Reports
  16. The role of vitamin D in multiple sclerosis and its mechanisms of action
    Agata Kowalczyk, Justyna Kiełbasa, Magda Przestrzelska, Aleksandra Rykucka, Marcin Wąs, Natalia Zozula, Zuzanna Tomczewska, Katarzyna Bil, Iga Ślesicka, Aleksandra Latała · 2024 · Quality in Sport
  17. Neuroinflammatory canine disorders: unveiling disease mechanisms from a One Health perspective
    Molly E. Church, Sara I Hernandez, Jorge Ivan Alvarez · 2025 · The Journal of Immunology
  18. Assessing the causal association between celiac disease and Alzheimer disease and frontotemporal dementia: A bidirectional Mendelian randomization approach
    Yu Liu, Hongmei Zhang · 2025 · Medicine
  19. Chemical Surface Modification Tolerance of Primary and Immortalized Macrophages and Stem Cells
    Kyle J. Winters, Yu‐I Shen, Emmanuel F. Rivera‐Iglesias, Jeffrey D. Cullen, Bishnu Prasad Joshi, Michelle E. Farkas · 2025 · ChemBioChem
  20. Blood-brain barrier integrity and prevalence of intrathecal T helper 17.1 cells in Huntington´s disease
    Birna Ásbjörnsdóttir, Christian Sandøe Musaeus, Marie N.N. Hellem, Tua Vinther‐Jensen, Patrick Ejlerskov, Esben Budtz–Jørgensen, Filippa Liliendahl Qvist, Anja Hviid Simonsen, Lena E. Hjermind, Niels Henning Skotte et al. · 2026 · PLoS ONE
  21. Ultrasound-driven nanotechnologies to overcome cancer immunotherapy resistance: From antigen presentation to metabolic rewiring
    Beibei Zhang, Xu Zhang, Siyi Yang, Mengmeng Sang, Yongfei Sha, Ge Chen, Suni Zhang, Jiahao Hu, Yuanmeng Gao, Rui Zhang et al. · 2026 · Colloids and Surfaces B Biointerfaces
  22. Human immunoglobulin G suppresses the production of matrix metalloproteinase‐9 in peripheral blood mononuclear cells of patients with multiple sclerosis
    Kazumasa Okada, Hiroaki Adachi · 2015 · Clinical and Experimental Neuroimmunology
  23. Disease Influence on BBB Transport in Inflammatory Disorders
    Geert J. Schenk, Gijs Kooij, Arie Reijerkerk, Helga E. de Vries · 2013 · AAPS advances in the pharmaceutical sciences series
  24. ROMATOİD ARTRİTTE BİLİŞSEL BOZUKLUĞUN DEĞERLENDİRİLMESİ: EKLEM YIKIMI VE HASTALIK AKTİVİTESİNİN BELİRLEYİCİ DEĞERİ
    Derya Güzel, Sinem Sağ, Mustafa Serdar Sağ, İbrahim Tekeoğlu, Ayhan Kamanlı, Kemal Nas · 2018 · Kocatepe tıp dergisi.
  25. Multiple Sclerosis: Unraveling the Neuropathology and Mechanisms of Neurodegeneration
    Samantha Visva, John Paul Oliveria · 2019 · McMaster University Medical Journal
  26. Drug Delivery Strategies for Tolerogenic Therapy for Autoimmune Diseases in an Antigen-Specific Manner
    Kevin J. Peine, Naihan Chen, Eric M. Bachelder, Kristy M. Ainslie · 2018 · IGI Global eBooks
  27. Pathologie und Immunpathogenese der Multiplen Sklerose
    Christine Stadelmann · 2013 · Springer eBooks
  28. Studying the blood–brain barrier will provide new insights into neurodegeneration – Commentary
    Stefan Bittner, Frauke Zipp · 2018 · Multiple Sclerosis Journal
  29. Significance of Autoantibodies
    Christiane S. Hampe · 2019 · Contemporary clinical neuroscience
  30. Imaging
    Neda Sattarnezhad, Joshua P. Klein · 2019 · Springer eBooks
  31. Clinical Example of Effective use of Biocompatible Magnetite (Fe3O4) Nanoparticles in the Complex Treatment of Multiple Sclerosis
    Andrey Belousov · 2023 · Nanomedicine & Nanotechnology Open Access
  32. Roles of CD4 and CD8 T Lymphocytes in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
    Nathalie Arbour, Alexandre Prat · 2015 · Wiley eBooks
  33. Using Experimental Autoimmune Encephalomyelitis to Identify Prospective Treatments for Multiple Sclerosis
    David O’Sullivan · 2012
  34. Therapeutic modulation of the blood-brain barrier and ischemic stroke by a bioengineered FZD 4 -selective WNT surrogate
    Jie Ding, Sung‐Jin Lee, Lukas J. Vlahos, Kanako Yuki, Cara Coleen Rada, Vincent van Unen, Meghah Vuppalapaty, Hui Chen, Asmiti Sura, Aaron K. McCormick et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  35. Peripheral endotoxin exposure in mice activates crosstalk between phagocytes in the brain and periphery
    Jake Sondag Boles, Oihane Uriarte Huarte, Malú G. Tansey · 2024 · Research Square
  36. Uncovering immune characteristics of neurons in the context of multiple sclerosis and experimental autoimmune encephalomyelitis
    Abdulshakour Mohammadnia, Sienna Drake, Stéphanie Zandee, David Gosselin, Jack Perry Antel, Alexandre Prat, Alyson E. Fournier · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Using Experimental Autoimmune Encephalomyelitis to Identify Prospective Treatments for Multiple Sclerosis
    David O’Sullivan · 2012 · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare)
  38. Complement factor H regulation in the central nervous system
    Laura Fraczek · 2011
  39. Treating GM1 Gangliosidosis With Ex Vivo Hematopoietic Stem Cell Gene Therapy Without Using Total Body Irradiation: A Masters Thesis
    Michael Whalen · 2011 · eScholarship@UMassChan
  40. Bone Marrow-Derived Cell Accumulation in the Brain in a Murine Model of Alzheimer’s Disease
    Christine Barr · 2013 · Summit (Simon Fraser University)
  41. Attenuation of Immune Suppression to Complement Glioma Immunotherapy
    Cameron S. Field · 2016 · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare)
  42. Exposure of neonatal rats to alcohol has differential effects on cytokine levels in the cerebellum and hippocampus : potential role of microglia and astrocytes
    Lauren A. Topper · 2015 · UNM’s Digital Repository (University of New Mexico)
  43. Central Nervous System Immune Inflammation
    Luke M. Healy, Hanane Touil, Vijayaraghava T.S. Rao, Mackenzie A. Michell‐Robinson, Jack Perry Antel, Roy O. Weller · 2016 · Elsevier eBooks
  44. Drug Delivery Strategies for Tolerogenic Therapy for Autoimmune Diseases in an Antigen-Specific Manner
    Kevin J. Peine, Naihan Chen, Eric M. Bachelder, Kristy M. Ainslie · 2016 · Advances in medical technologies and clinical practice book series
  45. Pathophysiology of the Blood–Brain Barrier in Neuroinflammatory Diseases
    Petra Majerová, Andrej Kováč · 2017 · Springer eBooks
  46. Immune Infiltration in Malignant Gliomas
    Neema Sadry, Raviteja Suryadevara, Prahlad Parajuli · 2018 · Elsevier eBooks
  47. Functional characterization of B- and T lymphocytes after aCD20 treatment in two different EAE models
    Linda Feldmann · 2017 · eDiss (Georg-August-Universität Göttingen)
  48. Envolvimento da enzima Piruvato Quinase M2 (PKM2) na diferenciação de linfócitos Th17 e patogênese da encefalomielite autoimune experimental
    Luis Eduardo Alves Damasceno · 2018
  49. The role of T cell subsets in experimental autoimmune encephalomyelitis
    Sarah C. Edwards · 2015 · Arrow@dit (Dublin Institute of Technology)
  50. Modelagem molecular das interações do complexo antígeno-anticorpo na investigação de doenças desmielinizantes autoimunes
    Jéssica Cristiane Magalhães Ierich · 2019
  51. The Effectiveness of Selective Stem Cell Placement on Gait Performance in Patients with Multiple Sclerosis: a Phase I Clinical Trial
    David S. Cohen, Henry Broeska · 2019 · International Journal of Pharmaceutical Sciences and Drug Research
  52. Design, Synthesis, and Biological Evaluation of Sphingosine 1-Phosphate Receptor (S1PR) Agonists
    Michael J. Ferracane · 2014
  53. Immunologie de la sclérose en plaques
    Gilles Louis Defer, Marc Debouverie, Isabelle Bardou, Mehdi Benamar, Raphaël Bernard‐Valnet, Pierre Branger, David Brassat, Naïl Benallegue, Floriane Calocer, Vincent Damotte et al. · 2019 · Elsevier eBooks
  54. Gut Microbiome and Depression
    Gal Winter, Robert A. de J. Hart, Richard P.G. Charlesworth, Christopher Francis Sharpley · 2020 · Oxford University Press eBooks
  55. The role of the astrocytic and microglial aryl hydrocarbon receptor in CNS demyelination
    Schmid, Susanne · 2020 · eDiss (Georg-August-Universität Göttingen)
  56. Immune cell infiltration characteristics and related core genes of bioinformatic analysis in multiple sclerosis
    Jingyu Zhao, Jianyong Zheng, Qun Wang, Qian Li, Nan Zhang · 2021 · Research Square
  57. Investigating the effects of novel heparan sulfate mimetic 'HS16-35' on immune cell migration in an in vitro model of the blood-CSF barrier.
    Maddie Griffiths · 2021
  58. Effects of dimethyl fumarate in two animal models of MS
    Sarah Traffehn · 2017 · eDiss (Georg-August-Universität Göttingen)
  59. Management and pathophysiology
    James Hong, Noah Poulin, Brian K. Kwon, Michael George Fehlings · 2022 · Elsevier eBooks
  60. Papel de los receptores TLR4 y de la microbiota intestinal en los procesos inflamatorios y neuroinflamatorios causados por el consumo crónico de alcohol, y posibles terapias con curcuminoides.
    Carlos Manuel Cuesta Díaz · 2022
  61. Kruppel-Like Factor 2 and Matrix Metalloproteinases in the Context of Vasculature
    Sarah Anderson, Derek Barthels, Hiranmoy Das · 2022 · Biology of extracellular matrix
  62. Oxygen Therapy for the Treatment of Experimental Autoimmune Encephalomyelitis
    Judy R. Wilson, Perry N. Fuchs · 2022 · Sports and Exercise Medicine - Open Journal
  63. The Use of a Nanotechnological Drug (MICROMAGE-B) in the Complex Treatment of Multiple Sclerosis
    Andrey Belousov · 2023 · ES Journal of Case Reports
  64. PDE4 gene inhibition
    Melissa Schepers · 2023 · Research Publications (Maastricht University)
  65. Emerging potential neuroregenerative strategies for degenerative cervical myelopathy
    Noah Poulin, Sydney T. Brockie, Tony Gengli, James Hong, Michael George Fehlings · 2023 · Elsevier eBooks
  66. T-Cells and Cd45-Cells Discovery in the Central Nervous System of Healthy and Nodavirus-Infected Teleost Fish Dicentrarchus Labrax
    Valeria Pianese, Daniel Álvarez‐Torres, Juan Gémez-Mata, Esther García‐Rosado, Patricia Moreno, Anna Maria Fausto, Anna Rita Taddei, Simona Picchietti, Giuseppe Scapigliati · 2024 · SSRN Electronic Journal
  67. The blood-brain barrier in multiple sclerosis
    Bettina Zierfuss, Marc Charabati, Brian A. MacVicar, Stéphanie Zandee, Alexandre Prat · 2024 · Elsevier eBooks
  68. Effective Application of Biocompatible Magnetite Nanoparticles in the Treatment of Multiple Sclerosis: Results of a Clinical Study
    2024 · Journal of Medical Clinical Case Reports
  69. The blood–brain barrier: Gatekeeper and obstacle in neurodegenerative disorders
    Mahmoud Bassiony, Marwa A. Ibrahem, Donia G. Youssef, Abdullah M. M. Elbadry, Omar A. Alaboudi · 2024 · Elsevier eBooks
  70. Immune Transformations for Therapeutic Gain in Neurodegenerative Disease
    Roshan Sapkota, Rodney Lee Mosley · 2024 · Springer eBooks
  71. Rethinking mental health: The body’s impact on the brain
    Georgia E. Hodes · 2025 · The Transmitter
  72. Multiple Sclerosis and the Blood–Cerebrospinal Fluid Barrier
    Brigitte Wildemann, Jürgen Haas · 2025 · Current human cell research and applications
  73. Navigating multiple sclerosis: From clinical categories to clinical management
    Isra Omar, Ahmed Alakhras, Samahir Mutwali, Moiz Bakhiet · 2025 · Brain Disorders
  74. The Role of T Cells in Alzheimer's Disease
    Yu‐Hsuan Lin, Hongfei Zhao, Dandan Meng, Min Wang · 2025 · Critical Reviews in Immunology
  75. The unexpected dual role of S100A9 amyloid protein on neurodegeneration in progressive multiple sclerosis motor cortex
    Jonathan Pansieri, Jonathan Atwood, Marco Pisa, Richard L. Yates, Gabriele C. DeLuca · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  76. Additional file 4 of The novel HS-mimetic, Tet-29, regulates immune cell trafficking across barriers of the CNS during inflammation
    Tessa Peck, Connor Davis, Georgia Ngawai Lenihan-Geels, Maddie Griffiths, Sam Spijkers‐Shaw, Olga V. Zubkova, Anne Camille La Flamme · 2024 · Figshare
  77. Additional file 1 of The novel HS-mimetic, Tet-29, regulates immune cell trafficking across barriers of the CNS during inflammation
    Tessa Peck, Connor Davis, Georgia Ngawai Lenihan-Geels, Maddie Griffiths, Sam Spijkers‐Shaw, Olga V. Zubkova, Anne Camille La Flamme · 2024 · Figshare
  78. Additional file 2 of Appearance of claudin-5+ leukocyte subtypes in the blood and CNS during progression of EAE
    Dylan Krajewski, Debayon Paul, Shujun Ge, Evan R. Jellison, Joel S. Pachter · 2021 · Figshare
  79. Additional file 5 of The novel HS-mimetic, Tet-29, regulates immune cell trafficking across barriers of the CNS during inflammation
    Tessa Peck, Connor Davis, Georgia Ngawai Lenihan-Geels, Maddie Griffiths, Sam Spijkers‐Shaw, Olga V. Zubkova, Anne Camille La Flamme · 2024 · Figshare
  80. Additional file 5 of Appearance of claudin-5+ leukocyte subtypes in the blood and CNS during progression of EAE
    Dylan Krajewski, Debayon Paul, Shujun Ge, Evan R. Jellison, Joel S. Pachter · 2021 · Figshare
  81. Additional file 3 of Appearance of claudin-5+ leukocyte subtypes in the blood and CNS during progression of EAE
    Dylan Krajewski, Debayon Paul, Shujun Ge, Evan R. Jellison, Joel S. Pachter · 2021 · Figshare
  82. Additional file 1 of Astrocytic stress response is induced by exposure to astrocyte-binding antibodies expressed by plasmablasts from pediatric patients with acute transverse myelitis
    Chad Smith, Kiel M. Telesford, Sara G. M. Piccirillo, Yamhilette Licón-Muñoz, Wei Zhang, Tse, Key M., Jacqueline R. Rivas, Chaitanya Joshi, Dilan S. Shah, Angela X. Wu et al. · 2024 · Figshare
  83. Additional file 3 of The novel HS-mimetic, Tet-29, regulates immune cell trafficking across barriers of the CNS during inflammation
    Tessa Peck, Connor Davis, Georgia Ngawai Lenihan-Geels, Maddie Griffiths, Sam Spijkers‐Shaw, Olga V. Zubkova, Anne Camille La Flamme · 2024 · Figshare
  84. Additional file 8 of Appearance of claudin-5+ leukocyte subtypes in the blood and CNS during progression of EAE
    Dylan Krajewski, Debayon Paul, Shujun Ge, Evan R. Jellison, Joel S. Pachter · 2021 · Figshare
  85. Additional file 6 of The novel HS-mimetic, Tet-29, regulates immune cell trafficking across barriers of the CNS during inflammation
    Tessa Peck, Connor Davis, Georgia Ngawai Lenihan-Geels, Maddie Griffiths, Sam Spijkers‐Shaw, Olga V. Zubkova, Anne Camille La Flamme · 2024 · Figshare
  86. Additional file 7 of Appearance of claudin-5+ leukocyte subtypes in the blood and CNS during progression of EAE
    Dylan Krajewski, Debayon Paul, Shujun Ge, Evan R. Jellison, Joel S. Pachter · 2021 · Figshare
  87. Additional file 6 of Appearance of claudin-5+ leukocyte subtypes in the blood and CNS during progression of EAE
    Dylan Krajewski, Debayon Paul, Shujun Ge, Evan R. Jellison, Joel S. Pachter · 2021 · Figshare
  88. Additional file 2 of Astrocytic stress response is induced by exposure to astrocyte-binding antibodies expressed by plasmablasts from pediatric patients with acute transverse myelitis
    Chad Smith, Kiel M. Telesford, Sara G. M. Piccirillo, Yamhilette Licón-Muñoz, Wei Zhang, Tse, Key M., Jacqueline R. Rivas, Chaitanya Joshi, Dilan S. Shah, Angela X. Wu et al. · 2024 · Figshare
  89. Additional file 2 of The novel HS-mimetic, Tet-29, regulates immune cell trafficking across barriers of the CNS during inflammation
    Tessa Peck, Connor Davis, Georgia Ngawai Lenihan-Geels, Maddie Griffiths, Sam Spijkers‐Shaw, Olga V. Zubkova, Anne Camille La Flamme · 2024 · Figshare
  90. Additional file 4 of Appearance of claudin-5+ leukocyte subtypes in the blood and CNS during progression of EAE
    Dylan Krajewski, Debayon Paul, Shujun Ge, Evan R. Jellison, Joel S. Pachter · 2021 · Figshare
  91. The Effect of Exercise on Myokine Levels in Multiple Sclerosis: IL-6, BDNF, Irısın and TNF- α
    Mustafa Aktar, Gürkan Demirtaş, Aslı ÇELİK · 2026 · Arşiv Kaynak Tarama Dergisi
  92. Modalités de recrutement des cellules microgliales dans le système nerveux central lésé chez la sangsue Hirudo medicinalis
    Annelise Bocquet-Garçon · 2012 · theses.fr (ABES)
  93. Contrôle de l'activation microgliale par les lymphocytes T dans un modèle murin de neurodégénérescence induite par la 6-OHDA
    Josselin Uhlrich · 2014 · theses.fr (ABES)
  94. Rôle glio-vasculaire de la dystrophine Dp71 : Altérations moléculaires et fonctionnelles chez un modèle murin déficient en Dp71
    Mehdi Belmaati Cherkaoui · 2019 · theses.fr (ABES)
  95. Regulation of the T cell response in Multiple Sclerosis
    Naïl Benallegue · 2021 · theses.fr (ABES)
  96. Celiac disease as a model of gut–brain autoimmunity: from gluten exposure to neuropsychiatric manifestations
    Valentina Pucinischi, Martina Piersanti, Giovanni Di Nardo, Matteo Guarino, Umberto Volta, Roberto DE GIORGIO, Renata Auricchio, Alessandro Ferretti, Pasquale Parisi, Maurizio Mennini · 2026 · Frontiers in Pediatrics
  97. Stem cell-derived extracellular vesicles as immunomodulatory agents: targeting pathological crosstalk in systemic lupus erythematosus and multiple sclerosis
    Lifei Yao, Qiong Li, Wei Peng, Sun Aimeng, Shaofen Li, Mengting Zou, Xianyun Xu · 2026 · Frontiers in Medicine
  98. Beyond B Cell Depletion: Adhesion and Activation Network Remodeling During Repeated Intravenous Anti-CD20 Therapy in Multiple Sclerosis
    Julia Feige, Tobias Moser, Katja Akgün, Kerstin Schwenker, Wolfgang Hitzl, Tjalf Ziemssen, Johann Sellner · 2026 · Neurology and Therapy
  99. The interplay between gut microbiota and Alzheimer’s disease: mechanistic insights from dysbiosis to disease modulation
    Kakali Das, R Khatun, Sanjana Begum, Koushik Bhattacharyya, Mallika Datta, Dipankar Saha, Anupam Sarma, Prachi Mehta, Bhrigu Kumar Das · 2026 · Metabolic Brain Disease
  100. Sex- and age-specific associations of VEGFA polymorphisms with multiple sclerosis susceptibility
    Kristė Kaikarytė, Simona Rubėnė, Alvita Vilkevičiūtė, Renata Balnytė, Ingrida Ulozienė, Rasa Liutkevičienė · 2026 · Annals of Medicine